Company Search:
Advanced Search
Sponsored Links
Dionymed Brands Inc Company Snapshot
Dionymed Brands Inc operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dionymed Brands Inc with three other pharmaceutical manufacturers in North America: Chromadex Corporation of the United States (2012 sales of $11.61 million of which 73% was Core Standards, Contract Services & Ingr), Zenabis Global Inc (18.90 million Canadian Dollars [US$14.24 million] ), and Savient Pharmaceuticals Inc. which is based in the United States ($18.02 million of which 100% was Specialty Pharmaceutical).

Sales Analysis.
  Stock Performance Chart for Dionymed Brands Inc
  Stock Data: Recent Stock Performance:
  Current Price (8/16/2019): 1.34
(Figures in Canadian Dollars)
1 Week -11.3%   13 Weeks -29.1%  
4 Weeks -46.4%   52 Weeks 665.7%  
Dionymed Brands Inc Key Data:
  Ticker: DYME Country: Canada
  Exchanges: VEN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2012 Sales 19,274,000
(Year Ending Jan 2013).
Employees: 32
  Currency: Canadian Dollars Market Cap: 27,061,687
  Fiscal Yr Ends: December Shares Outstanding: 20,195,289
  Share Type: Common Closely Held Shares: 6,602,799
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.